Tag Archives: Warren Woessner

BIO Joins Stakeholders in Expressing Concerns with Efforts to Restrict Gene Patenting

Today, the Secretary’s Advisory Committee on Genetics Health and Society (SACGHS), approved, with on dissent, a draft report which recommends legislative changes to the patent laws in regards to gene patents and recommends restrictions on licensing of federally funded research. … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , | Leave a comment

SACGHS Final Report on Gene Patents – Taking a Machete to the IP Thicket

On September 17, 2009, the Secretary of HHS’s Advisory Committee on Genetics, Health and Society (SACGHS) issued a Final Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests. The 66 page report … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , | Leave a comment

Court Decision in China Recognizes Novelty in Dosage Limitations in Swiss-Form Claims

Peksung Intellectual Property Ltd sent an interesting article (link below) reporting that the Higher People’s Court of Beijing held that both dosage form and dosage amount should be treated as limitations in Swiss-form claims. These “administration-related features” are often ignored … Continue reading

Posted in Non-U.S. Practice | Tagged , , , | Leave a comment

ESTHER KEPPLINGER JOINS PATENT PUBLIC ADVISORY COMMITTEE

I would like to congratulate Esther Kepplinger on her appointment by Commerce Secretary Locke to the Patent Public Advisory Committee, along with Steven W. Miller of P&G and Dr. Benjamin Borson. Although I have not always been sure just what … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , | Leave a comment